ARCHIVES

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

This article is from The Cancer Letter archive.

Vol. 37 No. 17 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Litton Sells Clinical Labs, Planning to Join Recompetition For FCRF Contracts

July 12, 1985

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB.

October 8, 2004

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

Edelson To Step Down As Yale Center Director.

January 11, 2008

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012